Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2) [1]

Journal of Medical Genetics

Volumn 37, Issue 12, 2000, Pages 944-947

  Evans, D G R ^a   Newton, V ^a   Neary, W ^a   Baser, M E ^a   Wallace, A ^a   Macleod, R ^a   Jenkins, J P R ^a   Gillespie, J ^a   Ramsden, R T ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AUDIOLOGY; BRAIN STEM RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; LETTER; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SCHOOL CHILD; SCREENING TEST;

ADOLESCENT; ADULT; AGE OF ONSET; AUDIOMETRY, EVOKED RESPONSE; AUDIOMETRY, PURE-TONE; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; GENETIC SCREENING; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROFIBROMATOSIS 2; PROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 0034532069     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. A clinical study of type 2 neurofibromatosis
2. A clinical, genetic and audiological study of patients and families with bilateral acoustic neurofibromatosis
3. Somatic mosaicism: A common mechanism for sporadic disease in tumor prone syndromes? Lessons from type 2 neurofibromatosis
4. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity
5. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for generic counselling
6. Germline mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities
7. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease
8. Genotype-phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease with truncating mutations
9. Identification of NF2 germline mutations and comparison with neurofibromatosis 2 phenotypes
10. Preservation of hearing in neurofibromatosis 2
11. Hearing preservation in neurofibromatosis type 2
12. Type 2 neurofibromatosis: The need for supraregional care?
13. NF2 gene in neurofibromatosis type 2 patients
14. Variation of expression of the gene for type 2 neurofibromatosis: Absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females
15. The neuro-imaging and clinical spectrum of neurofibromatosis 2
16. Uptake of genetic testing for cancer predisposition